169 related articles for article (PubMed ID: 9488398)
21. The enzymatic domain of Clostridium difficile toxin A is located within its N-terminal region.
Faust C; Ye B; Song KP
Biochem Biophys Res Commun; 1998 Oct; 251(1):100-5. PubMed ID: 9790914
[TBL] [Abstract][Full Text] [Related]
22. Inositol hexakisphosphate-dependent processing of Clostridium sordellii lethal toxin and Clostridium novyi alpha-toxin.
Guttenberg G; Papatheodorou P; Genisyuerek S; Lü W; Jank T; Einsle O; Aktories K
J Biol Chem; 2011 Apr; 286(17):14779-86. PubMed ID: 21385871
[TBL] [Abstract][Full Text] [Related]
23. Exchange of a single amino acid switches the substrate properties of RhoA and RhoD toward glucosylating and transglutaminating toxins.
Jank T; Pack U; Giesemann T; Schmidt G; Aktories K
J Biol Chem; 2006 Jul; 281(28):19527-35. PubMed ID: 16702216
[TBL] [Abstract][Full Text] [Related]
24. Glucosylation of Ras by Clostridium sordellii lethal toxin: consequences for effector loop conformations observed by NMR spectroscopy.
Geyer M; Wilde C; Selzer J; Aktories K; Kalbitzer HR
Biochemistry; 2003 Oct; 42(41):11951-9. PubMed ID: 14556626
[TBL] [Abstract][Full Text] [Related]
25. Functional implications of lethal toxin-catalysed glucosylation of (H/K/N)Ras and Rac1 in Clostridium sordellii-associated disease.
Genth H; Just I
Eur J Cell Biol; 2011 Nov; 90(11):959-65. PubMed ID: 21134703
[TBL] [Abstract][Full Text] [Related]
26. Low pH-induced formation of ion channels by clostridium difficile toxin B in target cells.
Barth H; Pfeifer G; Hofmann F; Maier E; Benz R; Aktories K
J Biol Chem; 2001 Apr; 276(14):10670-6. PubMed ID: 11152463
[TBL] [Abstract][Full Text] [Related]
27. Difference in Mono-O-Glucosylation of Ras Subtype GTPases Between Toxin A and Toxin B From
Genth H; Junemann J; Lämmerhirt CM; Lücke AC; Schelle I; Just I; Gerhard R; Pich A
Front Microbiol; 2018; 9():3078. PubMed ID: 30622517
[No Abstract] [Full Text] [Related]
28. Clostridium difficile and Clostridium sordellii toxins, proinflammatory versus anti-inflammatory response.
Popoff MR
Toxicon; 2018 Jul; 149():54-64. PubMed ID: 29146177
[TBL] [Abstract][Full Text] [Related]
29. Involvement of a conserved tryptophan residue in the UDP-glucose binding of large clostridial cytotoxin glycosyltransferases.
Busch C; Hofmann F; Gerhard R; Aktories K
J Biol Chem; 2000 May; 275(18):13228-34. PubMed ID: 10788427
[TBL] [Abstract][Full Text] [Related]
30. Structural consequences of mono-glucosylation of Ha-Ras by Clostridium sordellii lethal toxin.
Vetter IR; Hofmann F; Wohlgemuth S; Herrmann C; Just I
J Mol Biol; 2000 Sep; 301(5):1091-5. PubMed ID: 10966807
[TBL] [Abstract][Full Text] [Related]
31. Role of p38
Schelle I; Bruening J; Buetepage M; Genth H
Toxins (Basel); 2016 Dec; 9(1):. PubMed ID: 28025502
[TBL] [Abstract][Full Text] [Related]
32. Auto-catalytic cleavage of Clostridium difficile toxins A and B depends on cysteine protease activity.
Egerer M; Giesemann T; Jank T; Satchell KJ; Aktories K
J Biol Chem; 2007 Aug; 282(35):25314-21. PubMed ID: 17591770
[TBL] [Abstract][Full Text] [Related]
33. Evidence for differential roles of the Rho subfamily of GTP-binding proteins in glucose- and calcium-induced insulin secretion from pancreatic beta cells.
Kowluru A; Li G; Rabaglia ME; Segu VB; Hofmann F; Aktories K; Metz SA
Biochem Pharmacol; 1997 Nov; 54(10):1097-108. PubMed ID: 9464452
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the catalytic domain of Clostridium novyi alpha-toxin.
Busch C; Schömig K; Hofmann F; Aktories K
Infect Immun; 2000 Nov; 68(11):6378-83. PubMed ID: 11035748
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of synaptic neurotransmitter release mechanisms using bacterial toxins].
Doussau F; Humeau Y; Vitiello F; Popoff MR; Poulain B
J Soc Biol; 1999; 193(6):457-67. PubMed ID: 10783704
[TBL] [Abstract][Full Text] [Related]
36. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
Zeiser J; Gerhard R; Just I; Pich A
J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
[TBL] [Abstract][Full Text] [Related]
37. Clostridium difficile glucosyltransferase toxin B-essential amino acids for substrate binding.
Jank T; Giesemann T; Aktories K
J Biol Chem; 2007 Nov; 282(48):35222-31. PubMed ID: 17901056
[TBL] [Abstract][Full Text] [Related]
38. Phosphorylation of cellular proteins in response to treatment with Clostridium difficile toxin B and Clostridium sordellii toxin L.
Ciesielski-Treska J; Ulrich G; Baldacini O; Monteil H; Aunis D
Eur J Cell Biol; 1991 Oct; 56(1):68-78. PubMed ID: 1724754
[TBL] [Abstract][Full Text] [Related]
39. Cytosolic delivery and characterization of the TcdB glucosylating domain by using a heterologous protein fusion.
Spyres LM; Qa'Dan M; Meader A; Tomasek JJ; Howard EW; Ballard JD
Infect Immun; 2001 Jan; 69(1):599-601. PubMed ID: 11119561
[TBL] [Abstract][Full Text] [Related]
40. A phosphatidylserine-binding site in the cytosolic fragment of Clostridium sordellii lethal toxin facilitates glucosylation of membrane-bound Rac and is required for cytotoxicity.
Mesmin B; Robbe K; Geny B; Luton F; Brandolin G; Popoff MR; Antonny B
J Biol Chem; 2004 Nov; 279(48):49876-82. PubMed ID: 15383551
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
